Related by context. All words. (Click for frequent words.) 67 interferon gamma 1b 63 BRILINTA 63 RAPTIVA 62 sNDA submission 62 aleglitazar 62 Neulasta R 62 novel histone deacetylase 62 Soliris eculizumab 62 PF # [002] 62 Humira adalimumab 62 trastuzumab emtansine T DM1 62 ORAL Sync 62 PREOS R 61 GW# [003] 61 dextromethorphan quinidine 61 marketed pegylated interferons 61 COLAZAL R 61 Dacogen injection 61 phase IIb trial 61 PDE4 inhibitor 61 Syncria 61 Phase Ib II 61 trastuzumab DM1 T DM1 61 AVOREN 61 Cimzia certolizumab pegol 61 Besivance 61 Phase IIIb 61 Epirubicin 61 Amrubicin 60 PROVENGE ® 60 registrational studies 60 Nexavar sorafenib 60 nitric oxide donating prostaglandin 60 mertansine 60 Phase 2b clinical trials 60 RANK Ligand inhibitor 60 sunitinib malate 60 ongoing Phase 1b 60 Temsirolimus 60 acyclovir Lauriad ® 60 evaluating tivozanib 60 Taxotere docetaxel 60 miconazole Lauriad ® 60 phase IIb clinical 60 NVA# 60 volociximab 60 beta 1a 60 selective estrogen receptor modulator 60 trastuzumab DM1 60 EDEMA3 60 opioid induced bowel dysfunction 60 Auxilium Pharma 60 infusional 5-FU/LV 60 mesylate tablets 60 CIMZIA r 60 Androxal TM 60 Keppra XR 60 REMICADE infliximab 60 Trastuzumab DM1 60 docetaxel Taxotere R 60 evaluating satraplatin 60 ARCOXIA 60 BRIM2 60 Taxotere chemotherapy 60 CIMZIA ™ 60 eluting stent 60 Bazedoxifene 60 Gleevec imatinib mesylate 60 YONDELIS 59 CAELYX 59 R sorafenib tablets 59 investigational antiplatelet agent 59 Interferon beta 1a 59 LUCENTIS 59 vapreotide acetate 59 RezularTM 59 Alkeran 59 PDX pralatrexate 59 Trobalt 59 severe hypercholesterolemia 59 placebo controlled Phase III 59 CLL8 59 Vectibix panitumumab 59 ocular formulation 59 Phase 1b clinical 59 Fludara ® 59 Thalomid ® 59 Nexavar ® 59 Phase Ib study 59 Drug Eluting Stent System 59 LIALDA 59 FACTIVE R gemifloxacin 59 EXPAREL ™ 59 Levoleucovorin 59 Oxytrol R 59 Sanvar 59 Xelox 59 Topotecan 59 Tarceva TM 59 refractory chronic lymphocytic 59 SPRYCEL ® 59 FOLOTYN ® 59 phase IIb 59 paclitaxel Taxol ® 59 serotonin norepinephrine reuptake inhibitor 59 Somatuline R Depot 59 liposomal formulation 59 acyclovir Lauriad R 59 Iluvien ® 59 Eloxatin ® 59 SAR# [004] 59 #mg/#mg 59 LymphoStat B TM 59 methylnaltrexone bromide 59 Alair System 59 Aldara ® 59 DEB# 59 Quinamed 59 Rythmol SR 59 RELOVAIR ™ 59 Coreg CR 59 MAGE A3 ASCI 59 Orapred ODT 59 DUROS 59 Velcade bortezomib 59 Ixempra 59 Optiquel ™ 59 VISICOL R 59 IL# PE#QQR 59 nucleotide analogue 59 sevelamer carbonate 59 preclinical efficacy 59 markets HP Acthar 59 NASDAQ PCYC 59 Zenvia ™ 59 Hycamtin ® 59 Plicera 59 oritavancin semi 59 BRIM3 59 FOLFOX6 chemotherapy regimen 58 inhibitor RG# 58 Zenpep 58 Vitrasert R 58 Calcium Acetate 58 Targretin 58 erlotinib Tarceva ® 58 TRACON Pharmaceuticals 58 Clolar ® 58 P#X# antagonist 58 telomerase inhibitor drug 58 ALN HPN 58 Vernakalant 58 pegylated liposomal doxorubicin 58 Proquin XR 58 neratinib 58 ALGRX 58 candidate CRLX# 58 Gemzar ® 58 adenosine injection 58 Copegus ribavirin 58 JOULFERON 58 rosiglitazone maleate 58 sNDAs 58 THALOMID 58 immunotherapeutic agent 58 Vinorelbine 58 Febuxostat 58 Cleviprex TM clevidipine 58 phase IIb study 58 Actimmune ® 58 PD LID 58 evaluating REVLIMID 58 LUNESTA ® 58 Degarelix 58 Hycamtin 58 Marketing Authorisation Application MAA 58 Novantrone 58 PRIALT 58 GVAX ® 58 Avonex interferon beta 1a 58 SYCREST 58 randomized controlled Phase 58 TBC# 58 Taxotere ® 58 virus HCV protease inhibitor 58 IV acetaminophen 58 Cimzia ® certolizumab pegol 58 bortezomib Velcade 58 vinorelbine tartrate 58 BXT # 58 generation purine nucleoside 58 AERx iDMS 58 Squalamine 58 fostamatinib 58 desvenlafaxine 58 etanercept Enbrel 58 Xeloda ® 58 CIP TRAMADOL ER 58 Panzem R 58 LUCENTIS r 58 darinaparsin ZIO 58 Interferon alfa 58 COPEGUS 58 HCV protease inhibitor 58 brivaracetam 58 AVASTIN 58 BLA submission 58 PLAVIX ® 58 seliciclib CYC# 58 PEGylated interferon 58 metastatic hormone refractory 58 ANCHOR trial 58 Aryplase 58 dacarbazine chemotherapy 58 pulmonology portfolio 58 TELINTRA 58 Phase IIb clinical trials 58 albiglutide 58 APTIVUS 58 SUCCEED trial 58 PrevOnco ™ 58 elotuzumab 58 RECOTHROM R 58 Dual Opioid 58 OMNARIS Nasal Spray 58 Actimmune R 58 Cimzia R 58 Navelbine ® 58 Rebif ® 58 Zorbtive TM 58 Frova ® 58 fluocinolone acetonide 58 Zytiga 58 Presents Preclinical 58 BRAF inhibitor 58 Safinamide 58 Phase IIIb study 58 liver resection surgeries 58 application sNDA 58 ANYARA 58 AIR CF1 58 Pegasys ® 58 SmPC 58 topical gel formulation 58 pioglitazone HCl 58 Initiates Phase II 58 Phase IIIb clinical 58 Revlimid lenalidomide 58 Cimzia TM 58 MAA submission 58 octreotide acetate 58 TRANSFORMS 58 oral ridaforolimus 58 BLA filing 58 multicenter Phase II 58 novel emulsion formulation 58 trabectedin 57 nalbuphine ER 57 Rapaflo 57 PULMICORT 57 INSPIRE Trial Phase III 57 orally inhaled 57 Aplidin 57 Allovectin 7 57 Completes Patient Enrollment 57 INTEGRILIN ® 57 SNT MC# 57 Lenalidomide 57 Torisel 57 GAMMAGARD 57 Dificid 57 Lucentis ranibizumab 57 Phase #b/#a clinical 57 sitaxsentan 57 non nucleoside inhibitor 57 trastuzumab Herceptin R 57 MoxDuo IR 57 Evoltra ® 57 ADVANCE PD 57 ONCASPAR 57 thalidomide Thalomid 57 THALOMID R 57 Lenocta 57 fenofibric acid 57 Romiplostim 57 Vimpat ® lacosamide 57 low dose cytarabine 57 Nasdaq PGNX today 57 Dapagliflozin 57 Retisert R 57 TAXUS Element Stent System 57 developing Bicifadine serotonin 57 T Pred 57 lexidronam injection 57 gemcitabine Gemzar 57 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 57 tramadol ER 57 ADP receptor antagonist 57 Ampligen ® 57 CORDAPTIVE 57 QUADRAMET R 57 AIR CF2 57 cathepsin K inhibitor 57 IMiD 57 Firazyr 57 Ridaforolimus 57 tramiprosate Alzhemed TM 57 MERREM IV 57 Xanafide 57 Pegintron 57 arsenic trioxide injection 57 balsalazide tablet 57 Voraxaze 57 PRT# 57 FDA Approvable Letter 57 Eraxis 57 standard chemotherapy regimen 57 Tiuxetan 57 ketolide antibiotic 57 HCl capsules 57 novel oral anticoagulant 57 indacaterol 57 FROVA 57 Edoxaban 57 Ranibizumab 57 investigational antiplatelet 57 Raptiva R 57 novel synthetic peptide 57 Celgene Thalomid 57 Clevudine 57 phase III isavuconazole 57 HGS# 57 Pemetrexed 57 BIIB# 57 MabThera rituximab 57 PSMA ADC 57 inhaled AAT 57 Sutent sunitinib malate 57 induced macular edema 57 Increlex R 57 ONGLYZA ™ 57 Proleukin 57 Saforis 57 corticotropin injection 57 Camptosar ® 57 phase IIIb 57 Dynavax HBV vaccine 57 Liprotamase 57 FOLFIRI 57 subcutaneous formulation 57 HepaMate 57 docetaxel Taxotere 57 Onco TCS 57 Vancocin R 57 Motesanib 57 TELINTRA R 57 pan HDAC inhibitor 57 NSABP C 57 panitumumab Vectibix 57 Ranexa R 57 Orphan Drug designations 57 ularitide 57 pegylated interferons 57 orally disintegrating 57 torcetrapib atorvastatin 57 chemotherapy FOLFOX 57 Xenazine ® 57 ChemGenex Pharmaceuticals Limited 57 Byetta exenatide 57 Omnitarg 57 ISENTRESS raltegravir 57 liposome injection 57 MIVI III 57 exenatide Byetta 57 Phase Ib clinical 57 EXPAREL TM 57 oral nucleoside analogue 57 Phase III ThermoDox 57 sapropterin dihydrochloride 57 SILENOR 57 OLUX 57 OvaRex ® MAb 57 SUTENT ® 57 Pegasys peginterferon alfa 2a 57 pertuzumab 57 Breezhaler ® 57 REBETOL combination therapy 57 oxymorphone ER 57 ANDAs pending approval 57 sorafenib Nexavar 57 Phase lll 57 Telatinib 57 MKC# MKC# PP 57 PEGINTRON TM 57 FDA APPROVES 57 AVONEX ® 57 subcutaneously administered 57 pemetrexed Alimta 57 fosbretabulin 57 Argatroban 57 oral cladribine 57 CHAMPION PCI 57 Aranesp darbepoetin alfa 57 Tracleer R 57 Orencia abatacept 57 Uvidem 57 Sanofi Aventis Taxotere 57 Gemzar gemcitabine 57 non peptidic protease 57 Ciclesonide 57 xanthine oxidase inhibitor 57 somatostatin analog 57 ritonavir boosted atazanavir 57 ZEGERID Capsules 57 UPLYSO 57 Diovan Exforge Tekturna Zelnorm 56 Bicalutamide 56 initiated Phase Ib 56 ZACTIMA 56 Daliresp 56 Tracleer r 56 Diabetic Macular Edema DME 56 reslizumab 56 SinuNase ™ 56 Beyond Advair 56 ALN VSP Phase 56 Proellex TM 56 Benicar ® 56 Ticagrelor 56 AzaSite TM 56 fludarabine phosphate 56 teriflunomide 56 hydrochloride capsules 56 nasal calcitonin product 56 Lomitapide 56 tenofovir emtricitabine 56 ALVESCO ® 56 INVANZ 56 buccal spray 56 Glatiramer Acetate 56 anti angiogenic agent 56 mTOR inhibitor 56 huC# DM4 56 INTEGRILIN 56 Panzem ® 56 Betaseron ® 56 AzaSite Plus 56 Lexiscan ® 56 Panzem R NCD 56 OZURDEX ® 56 Oracea R 56 Phase 1b trial 56 Aflibercept 56 Ambrisentan 56 Kuvan sapropterin dihydrochloride 56 Xcytrin R 56 Biologic License Application BLA 56 compound ITMN 56 investigational humanized monoclonal antibody 56 biologic DMARD 56 COMFORT II 56 INC# 56 Boniva ibandronate 56 FAME Study 56 Pivotal Trial 56 relapsed refractory multiple myeloma 56 5 fluorouracil leucovorin 56 BR.# 56 DexaSite 56 oral prodrug 56 Remicade infliximab 56 preclinical pharmacokinetic 56 metaglidasen 56 acetonide FA 56 evaluating mipomersen 56 RELISTOR ® 56 Dasatinib 56 aflibercept 56 goserelin 56 Biological License Application 56 bevacizumab Avastin 56 Exforge HCT 56 k Premarket Notification 56 Asentar TM 56 plus DOXIL 56 oxaliplatin Eloxatin 56 enoxaparin sodium injection 56 ara C 56 gemcitabine Gemzar R 56 sumatriptan injection 56 Rituxan rituximab 56 R bendamustine hydrochloride 56 Zocor simvastatin 56 Yondelis ® 56 QNEXA 56 Fanapt iloperidone 56 risedronate sodium tablets 56 MERREM 56 PEG interferon 56 CancerVax Corporation 56 IMA# 56 plus gemcitabine 56 cytokine refractory 56 Inhalation Aerosol 56 modulator SERM 56 CIMZIA TM certolizumab pegol 56 ENMD # 56 Soriatane 56 YONDELIS R 56 Peginterferon alfa 2b 56 Tekturna HCT 56 iloprost Inhalation Solution 56 proteasome inhibitor 56 Pazopanib 56 cetuximab Erbitux 56 vinca alkaloid 56 methylnaltrexone 56 Xibrom TM 56 JAK3 inhibitor 56 Achieves Primary Endpoint 56 Abacavir 56 SPD# 56 alpha interferons 56 Vidaza azacitidine 56 LAF# 56 sumatriptan succinate 56 Phase #/#a 56 RoACTEMRA 56 Adenoscan R 56 topical ophthalmic 56 JAK inhibitor 56 INTUNIV TM 56 rasagiline tablets 56 ThermoDox R 56 OMP designation 56 Kosan dependence 56 Tezampanel 56 midstage trials 56 CDP# 56 evaluating carfilzomib 56 nilotinib Tasigna 56 Renvela ® 56 Vicriviroc 56 deforolimus 56 long acting muscarinic 56 Valtropin 56 aspirin clopidogrel 56 viral kinetic 56 ANTEGREN 56 CRMD# 56 LHRH antagonists 56 NUVIGIL ® 56 combines bupropion 56 Zometa zoledronic acid 56 Tykerb lapatinib 56 vidofludimus 56 Amlodipine Besylate Tablets 56 Partnering Guide 56 HepeX B TM 56 RAPTIVA r 56 Phase IIa trials 56 ACOMPLIA R 56 Tasigna nilotinib 56 TAXUS Element Paclitaxel Eluting 56 forodesine 56 ARIKACE ™ 56 Genentech Rituxan 56 rotigotine transdermal patch 56 Avastin bevacizumab 56 Aurora kinase inhibitor 56 Phase III confirmatory 56 HCV polymerase inhibitors 56 TRISENOX 56 MKC# 56 randomized controlled multicenter 56 pediatric Crohn disease 56 active comparator 56 product Zingo TM 56 comparator arm 56 squamous non 56 somatostatin analogue 56 Sanvar R 56 Prostate AdenoCarcinoma Treatment 56 Pivotal Phase III 56 docetaxel Taxotere ® 56 NeuroSTAT ® 56 gemcitabine carboplatin 56 hormone agonist 56 diclofenac sodium 56 ribavirin Copegus 56 Fingolimod 56 alemtuzumab Campath 56 Octreolin 56 atrasentan 56 PEG INTRON R 56 PegIntron 56 Solzira 56 hyaluronidase enzyme 56 SANVAR 56 ritonavir boosted 56 Sutent sunitinib 56 DASISION 56 KALBITOR ® 56 Files Investigational 56 corticosteroid dexamethasone 56 Cloretazine VNP#M 56 MOVIPREP R 56 CIP ISOTRETINOIN 56 entacapone 56 non squamous NSCLC 56 oral chemotherapeutic agent 56 iniparib 56 oral diclofenac 56 BLP# Liposome Vaccine 56 sorafenib tablets 56 quetiapine fumarate 56 Alvesco R 56 Marketing Authorisation Application 56 rThrombin 56 efalizumab 56 evaluating picoplatin 56 Ropinirole 56 Cloretazine ® 56 PANVAC VF 56 vilanterol 56 SUPPRELIN R LA 56 Sprycel dasatinib 56 phase 2a 56 Lovaza TM 56 Alnylam ALNY 56 sargramostim 56 PROMACTA ® 56 axitinib 56 candidate iSONEP TM 56 Bristol Myers Squibb Sprycel 56 Durezol TM 56 Elvitegravir 56 Phase 1b 56 Vfend 56 TEMODAL 56 Actemra tocilizumab 56 Fast Track Status 56 Presents Preclinical Data 56 capecitabine Xeloda 56 Benazepril 56 Phase 2b clinical 56 Copegus ® 56 vosaroxin 56 SPIRIVA HandiHaler 56 enzastaurin 56 multicenter multinational 56 Amnesteem 56 SPL# Gel vaginal microbicide 56 Entocort EC 56 Solaraze 56 Targretin capsules 55 CRLX# 55 Dexilant 55 Phase 1a clinical 55 Paraplatin 55 ZOLINZA 55 topically applied SEPA 55 peginterferon alfa 2b 55 PEG IFN 55 Palifosfamide 55 ROTATEQ 55 Erlotinib 55 baminercept 55 Receives Approvable Letter 55 Focalin XR ® 55 daptomycin 55 Serdolect ® 55 Investigational Oral 55 SinuNase TM 55 Vimpat lacosamide 55 CIMZIA TM 55 Zenvia Phase III 55 BCR ABL inhibitor 55 ® bendamustine hydrochloride 55 sapacitabine CYC# 55 Phase #b/#a 55 Taxol paclitaxel 55 Votrient 55 pharmacologically active isomer 55 QVA# 55 Avandaryl 55 Mipomersen 55 PEG SN# 55 Vaprisol 55 BYETTA ® 55 Oxcarbazepine 55 Alvesco ® 55 lenalidomide Revlimid 55 Afinitor everolimus 55 Sunovion 55 intravenous AAT 55 candidate AQ4N 55 gallium nitrate injection 55 Metvix 55 Gralise 55 CERVARIX R 55 phase IIa 55 HuMax CD4 55 multi kinase inhibitor 55 Nebido 55 VYTORIN ezetimibe simvastatin 55 Roche OTC RHHBY 55 temsirolimus 55 PROVENGE sipuleucel T 55 Pirfenidone 55 Hedgehog Pathway Inhibitor 55 midstage clinical 55 Seroquel quetiapine fumarate 55 muraglitazar 55 Fenoglide 55 Evoltra 55 vismodegib 55 NDA Submission 55 melphalan prednisone 55 regorafenib 55 fluvastatin 55 ULTRASE 55 Requip XL 55 ziprasidone Geodon 55 Panzem NCD 55 Galantamine 55 oxybutynin chloride 55 Elitek 55 lasofoxifene 55 epoetin zeta 55 IIa trial 55 Neupogen ® 55 OSI Tarceva 55 miconazole Lauriad R 55 Omacor ® 55 TRISENOX R 55 hypoxia activated prodrug 55 ARCALYST ® 55 Genasense ® oblimersen 55 Trelstar R 55 Regeneron Pharma 55 relapsing multiple sclerosis 55 evaluating Actimmune 55 Arimidex anastrozole 55 Qutenza TM 55 Novartis Reclast 55 interferon alfa 2b 55 vincristine doxorubicin 55 Roche Pegasys 55 oseltamivir Tamiflu ® 55 RAPAFLO TM 55 ALN HTT 55 Iloperidone 55 metastatic colorectal carcinoma 55 orally administered inhibitor 55 lenalidomide dexamethasone 55 gastrin analogue TT 55 R lenalidomide 55 anticancer compound 55 CVac 55 Loramyc ™ 55 Spiegelmer ® 55 IN.PACT Falcon 55 NSABP B 55 ACAPODENE 55 IMiDs R 55 histone deacetylase HDAC inhibitor 55 octreotide implant 55 Horizant ™ 55 DPP4 inhibitor 55 STEDESA 55 intravenous acetaminophen 55 Orathecin 55 Ceflatonin R 55 Fodosine 55 cetuximab Erbitux ® 55 Pravachol pravastatin 55 Neurodex 55 Xyrem ® 55 Receives Orphan Drug 55 oral renin inhibitor 55 BEMA TM Fentanyl 55 gemcitabine Gemzar ® 55 cetuximab Erbitux R 55 Orazol 55 verteporfin 55 MERLIN TIMI 55 Multiple Ascending Dose 55 Retisert ® 55 placebo controlled Phase 55 DYSPORT 55 leading oral taxane 55 latrepirdine 55 neovascular age 55 Soriatane R 55 Cellegesic 55 Vascular Wrap TM 55 BiTE R 55 hoFH 55 phase IIa clinical 55 Certolizumab 55 aripiprazole Abilify 55 Sorafenib HCC Assessment 55 antibiotic Tygacil 55 Loramyc R 55 Glatiramer acetate 55 Isavuconazole 55 Onbrez ® 55 nonsedating antihistamine 55 Vilazodone 55 Tyzeka 55 tolevamer 55 Piperacillin 55 herpetic keratitis 55 Dacogen decitabine 55 OPAXIO 55 AZILECT R 55 Fanapt ® 55 Albugon 55 Pruvel 55 Files IND 55 pharmacodynamic profiles 55 Ampligen R 55 ANDA submission 55 Alpha interferons including 55 NPS NPS Pharmaceuticals 55 rilonacept 55 MNTX 55 Roche Boniva 55 Movectro 55 gemcitabine cisplatin 55 selective androgen receptor modulator 55 ROCKET AF 55 granulated mesalamine 55 pegylated interferon alfa 2b 55 DU #b 55 Omnaris 55 Icatibant 55 pharmacokinetic PK study 55 Initiated Phase 55 Orphan Drug status 55 Allovectin 7 ® 55 prodrug stimulant 55 placebo controlled clinical 55 Granted Orphan Drug 55 HoFH 55 Erbitux cetuximab 55 granisetron formulated 55 bazedoxifene 55 Vitaxin 55 Truvada emtricitabine 55 Sycrest 55 Peg IFN 55 NUEDEXTA ™ 55 Albuferon TM 55 Denufosol 55 Zegerid OTC 55 Focalin XR R 55 Announces Tentative Approval 55 Proxinium TM 55 Tanespimycin 55 alvespimycin 55 galantamine hydrobromide 55 dose escalation Phase 55 ALN PCS 55 interferon alfa 55 VARIVAX 55 levodopa carbidopa 55 darunavir r 55 RAPTIVA R 55 Elan NanoCrystal 55 SCHWARZ PHARMA 55 HYLENEX recombinant 55 Therapeutic Competitors companiesandmarkets.com adEgemonye 55 INS# [001] 55 Elagolix 55 INCB# [001] 55 ® daptomycin 55 pan histone deacetylase 55 Starlix 55 Ellence 55 ASCO GI 55 metformin sulfonylurea 55 BUPHENYL 55 ORENCIA ® 55 cyclophosphamide doxorubicin vincristine 55 adecatumumab MT# 55 drug eluting coronary stent 55 torsemide ER 55 posaconazole 55 SinuNase 55 RITUXAN 55 angiogenesis inhibitor 55 #mg dosage strength 55 anthracyclines taxanes 55 Interferon alpha 55 PROMUS Element Stent 55 ribavirin RBV 55 confirmatory Phase III 55 ENTOCORT EC 55 pazopanib 55 Pfizer Camptosar 55 alfa 2a 55 albinterferon alfa 2b 55 pradefovir 55 Dalbavancin 55 drug Treanda 55 TheraCIM 55 Phase Ib 55 Onrigin TM 55 labial herpes 55 atypical antipsychotic medication 55 XL# anticancer compounds 55 estramustine 55 FIRAZYR 55 Alzhemed TM 55 Neupro R 55 oral Azacitidine 55 ceftazidime 55 Teplizumab 55 FDA approvable letter 55 TAXUS TM 55 tinidazole 55 ACUROX ® 55 Zirgan 55 dalbavancin 55 plus dexamethasone 55 REYATAZ R 55 Ozurdex 55 Fibrin Pad 55 gemcitabine chemotherapy 55 microtubule inhibitor 55 cisplatin gemcitabine 55 ASTEROID 55 Trandolapril 55 ponatinib 55 Mirapexin 55 Kepivance 55 Dementia Related Psychosis 55 Factor VIIa 55 5 HT3 antagonist 55 REMINYL ® 55 Entocort 55 Bristol Myers Squibb Pravachol 55 Copegus R 55 ruboxistaurin 55 intranasal formulations 55 Vandetanib 55 Aceon 55 KNS # 55 cediranib 55 GTC recombinant human 55 PrevOnco 55 ARIXTRA 55 Amex ANX 55 zinc cysteine 55 Phase III placebo controlled 55 BUPHENYL R 55 XOPENEX HFA 55 tubulin inhibitor 55 dirucotide 55 TRX1 55 quinolone antibiotic 55 Junovan 55 Gammagard Liquid 55 Erythropoiesis Stimulating Agent 55 calcineurin inhibitor 55 PEGylated anti 55 Cetuximab Erbitux 55 CRTX 55 zotarolimus 55 Treanda bendamustine 55 Pennsaid ® 55 PROMUS Element Stent System 55 Vidaza R 55 Orally administered 55 Aloxi ® 55 Candesartan 55 UVIDEM 55 AMRIX R 55 OROS ® 55 Study Evaluating 55 bazedoxifene conjugated estrogens 55 dacarbazine DTIC 55 Begins Dosing 55 endothelin antagonist 55 Nexavar tablets 55 antibiotic Avelox 55 NXL# 55 Phase 2a clinical 55 Alimta pemetrexed 55 DuraSite ® 55 NEUPOGEN 55 small molecule Hedgehog 55 HuLuc# 55 Captisol Enabled 55 Dyloject TM 55 CD HORIZON 55 PERSEUS clinical program